Skip to main content
Premium Trial:

Request an Annual Quote

Left BARDA Behind

Rick Bright is no longer the head of the Biomedical Advanced Research and Development Authority, the agency at the center of the US response to the SARS-CoV-2 pandemic, Stat News reports.

BARDA has been supporting efforts by Johnson & Johnson and Moderna to develop vaccines against SARS-CoV-2, and, as Stat News notes, the agency saw its budget more than triple as part of the recent coronavirus stimulus package. CNN adds that Bright had led BARDA since 2016 and, before that, he directed its Influenza and Emerging Infectious Diseases Division.

But the reason for Bright's departure is unclear, Stat News adds, noting there have been reports of "chafing" between him and Bob Kadlec, the Department of Health and Human Services assistant secretary for preparedness and response. 

An HHS spokesperson tells Stat News that Bright is moving to the National Institutes of Health to work on diagnostics. "Bright will transfer the skills he has applied as Director of the Biomedical Advanced Research and Development Authority (BARDA) to the National Institutes of Health, as part of a bold plan to accelerate the development and deployment of novel point-of-care testing platforms," says HHS spokesperson Caitlin Oakley, according to Bloomberg News.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.